Technology areas: Biotechnology & Pharmaceuticals • Computing & Software
9 pending office actions • 9 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Wuhan University maintains a diverse prosecution profile in Biotechnology & Pharmaceuticals with 9 pending office actions. Each of these 9 actions is handled by a different person, as the data shows 9 distinct examiners are involved. Furthermore, the portfolio is spread across 9 distinct art units, indicating a broad range of specialized technical subject matter within the biotechnology sector. This distribution suggests that the university's patenting activities cover a wide array of distinct technological niches rather than being concentrated in a single sub-discipline.
The busiest examiner for this institution is ORTIZ RODRIGUEZ, CARLOS R, who is currently managing 1 pending office action. Because there are 9 pending office actions and 9 distinct examiners, no single examiner holds a plurality of the active cases. The presence of 9 distinct art units for 9 pending office actions means that every active matter is being reviewed in a different specialized group. This decentralized structure requires the university to navigate a variety of examination styles and technical standards across the patent office.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (22%) |
| §103 only | 2 (22%) |
| §112 only | 2 (22%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ORTIZ RODRIGUEZ, CARLOS R | 1 | 77.2% | +10.6% |
| GUINO-O UZZLE, MARITES A | 1 | 69.2% | +16.6% |
| LIPPERT, JOHN WILLIAM | 1 | 59.2% | +39.9% |
| PETRASH, HILARY ANN | 1 | 65.6% | +50.2% |
| ORTIZ, ELIM | 1 | 79.4% | +22.8% |
| YU, DELPHINUS DOU YI | 1 | 33.3% | +0.0% |
| HANEY, AMANDA MARIE | 1 | 36.5% | +45.0% |
| MUMMERT, STEPHANIE KANE | 1 | 61.4% | +21.2% |
| BEVERIDGE, CONNOR HAMMOND | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17871649 | BIORETROSYNTHETIC METHOD AND SYSTEM BASED ON AND-OR TREE AND SINGLE-STEP REACTION TEMPLATE PREDICTION | BEVERIDGE, CONNOR HAMMOND | 27d |
| 18415188 | COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA | PETRASH, HILARY ANN | — |
| 18406179 | WEAKLY-CENTRALIZED FREQUENCY REGULATION CONTROL METHOD OF CHARGE STATION CLUSTER BASED ON VIRTUAL LEADER AND MEDIUM | ORTIZ, ELIM | — |
| 18277768 | EDITING OF DOUBLE-STRANDED DNA WITH RELAXED PAM REQUIREMENT | YU, DELPHINUS DOU YI | — |
| 18271654 | COMPOSITIONS AND METHODS FOR INSTANT NUCLEIC ACID DETECTION | HANEY, AMANDA MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18584761 | COMPOSITION INCLUDING A METAL-ORGANIC FRAMEWORK (MOF) NANOPARTICLE FOR ORAL PROTEIN ADMINISTRATION | LIPPERT, JOHN WILLIAM | 30d overdue |
| 18605657 | SIMILAR MATERIAL FOR ROCK SLOPE MODEL TEST UNDER WATER-ROCK INTERACTION, AND PREPARATION METHOD AND USE THEREOF | GUINO-O UZZLE, MARITES A | 17d overdue |
| 18105233 | MOLECULAR BEACON BASED NANOPROBES FOR DIRECTLY DETECTING ORGAN-SPECIFIC MATASTASIS RELATED BIOMARKERS OF TUMOR CELLS IN PERIPHERAL BLOOD, PREPARATION METHOD AND APPLICATION | MUMMERT, STEPHANIE KANE | 83d |
| 18736597 | FLOAT-DISCRETE DIFFERENTIAL DYNAMIC PROGRAMMING SUCCESSIVE APPROXIMATION METHOD FOR CASCADE RESERVOIR GROUP SCHEDULING | ORTIZ RODRIGUEZ, CARLOS R | — |
| 18415188 | COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA | PETRASH, HILARY ANN | — |
| 18406179 | WEAKLY-CENTRALIZED FREQUENCY REGULATION CONTROL METHOD OF CHARGE STATION CLUSTER BASED ON VIRTUAL LEADER AND MEDIUM | ORTIZ, ELIM | — |
| 18271654 | COMPOSITIONS AND METHODS FOR INSTANT NUCLEIC ACID DETECTION | HANEY, AMANDA MARIE | — |
| Art Unit | Apps |
|---|---|
| 2119 | 1 |
| 1731 | 1 |
| 1615 | 1 |
| 1644 | 1 |
| 2117 | 1 |
| 1636 | 1 |
| 1682 | 1 |
| 1681 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18736597 | FLOAT-DISCRETE DIFFERENTIAL DYNAMIC PROGRAMMING SUCCESSIVE APPROXIMATION METHOD FOR CASCADE RESERVOIR GROUP SCHEDULING | ORTIZ RODRIGUEZ, CARLOS R | 2119 | §112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18605657 | SIMILAR MATERIAL FOR ROCK SLOPE MODEL TEST UNDER WATER-ROCK INTERACTION, AND PREPARATION METHOD AND USE THEREOF | GUINO-O UZZLE, MARITES A | 1731 | §112 | Final Rejection | 17d overdue | Pending | Mar 14, 2024 |
| 18584761 | COMPOSITION INCLUDING A METAL-ORGANIC FRAMEWORK (MOF) NANOPARTICLE FOR ORAL PROTEIN ADMINISTRATION | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 30d overdue | Pending | Feb 22, 2024 |
| 18415188 | COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA | PETRASH, HILARY ANN | 1644 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 17, 2024 |
| 18406179 | WEAKLY-CENTRALIZED FREQUENCY REGULATION CONTROL METHOD OF CHARGE STATION CLUSTER BASED ON VIRTUAL LEADER AND MEDIUM | ORTIZ, ELIM | 2117 | §102§112 | Non-Final OA | — | Pending | Jan 07, 2024 |
| 18277768 | EDITING OF DOUBLE-STRANDED DNA WITH RELAXED PAM REQUIREMENT | YU, DELPHINUS DOU YI | 1636 | §102§103Other | Non-Final OA | — | Pending | Aug 17, 2023 |
| 18271654 | COMPOSITIONS AND METHODS FOR INSTANT NUCLEIC ACID DETECTION | HANEY, AMANDA MARIE | 1682 | §102§103§112 | Non-Final OA | — | Pending | Jul 10, 2023 |
| 18105233 | MOLECULAR BEACON BASED NANOPROBES FOR DIRECTLY DETECTING ORGAN-SPECIFIC MATASTASIS RELATED BIOMARKERS OF TUMOR CELLS IN PERIPHERAL BLOOD, PREPARATION METHOD AND APPLICATION | MUMMERT, STEPHANIE KANE | 1681 | §103 | Final Rejection | 83d | Pending | Feb 02, 2023 |
| 17871649 | BIORETROSYNTHETIC METHOD AND SYSTEM BASED ON AND-OR TREE AND SINGLE-STEP REACTION TEMPLATE PREDICTION | BEVERIDGE, CONNOR HAMMOND | 1687 | §101§103 | Final Rejection | 27d | Pending | Jul 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWuhan University has 9 pending office actions as of October 2026, spread across 9 art units and 9 examiners.
Carlos R Ortiz Rodriguez has the most, with 1 of Wuhan University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
